Cipla Health Launches Omnigel Maxstrong, Expands P...
Category : Approval/Launch 8 July 2026Omnigel Introduces a New Pain Relief Product Cipla Health has announced the launch of Omnigel Max...
Newsletter - All News
Newsletter- All News is a comprehensive section of updated news and current trends, specifically curated to keep clinical trials, including breakthroughs in drug research, regulatory approvals, and advancements in study methodologies. Our news covers key trends in trial designs, patient recruitment strategies, and cutting-edge technologies shaping the future of clinical research
ReproNovo Doses First Participant in Phase 2 NORDI...
Category : Clinical Trial Update 8 July 2026ReproNovo Starts Phase 2 Clinical Trial in Europe ReproNovo has announced that the first particip...
EnteroBiotix Doses First Patient in Phase 2b RISE...
Category : Clinical Trial Update 8 July 2026EnteroBiotix Reaches a New Clinical Milestone EnteroBiotix Limited has announced that the first p...
Brii Bio Reports Positive Phase 2b Results for BRI...
Category : Clinical Trial Update 7 July 2026End-of-Treatment Data Highlights Strong HBsAg Loss in Sequential Treatment Study Brii Biosciences...
Immunomic Therapeutics Doses First Participant in...
Category : Clinical Trial Update 7 July 2026Phase 1 Clinical Trial Begins in Japan Immunomic Therapeutics Inc. (ITI), a clinical-stage biotec...
Latest Newsletter Post
-
EnteroBiotix Doses First Patient in..
8 July 2026
-
ReproNovo Doses First Participant i..
8 July 2026
-
Cipla Health Launches Omnigel Maxst..
8 July 2026
-
AtaiBeckley Completes Patient Dosin..
7 July 2026
-
Immunomic Therapeutics Doses First..
7 July 2026
